Switch to:
More From Other Websites
11 promising drugs poised to be the next billion-dollar blockbusters Mar 27 2015
Source to Close Europe ETF Mar 27 2015
Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog Mar 26 2015
Genzyme Convenes Sixth Annual Gaucher Leadership Forum Mar 26 2015
ENCORE Clinical Data Published in The Lancet Suggest Treatment with Oral Maintenance Therapy... Mar 25 2015
Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years... Mar 25 2015
Isis Pharmaceuticals Reports Phase I Data on Lipid Candidate - Analyst Blog Mar 24 2015
11 Promising New Drugs Expected to Make Billions in Sales Mar 23 2015
Amicus to Seek for Migalastat's Approval in the U.S., EU - Analyst Blog Mar 20 2015
Sanofi Inks Multi-Component Strategic Deal with Evotec - Analyst Blog Mar 20 2015
Goldman Downgrade Makes MannKind A Buy Mar 20 2015
Evotec and Sanofi Sign Definitive Agreement for Major Multi-Component Strategic Alliance Mar 19 2015
Mark Levin to be honored with MassBio's annual Termeer award Mar 19 2015
Amicus Up As FDA, EU Green-light Quick Drug Filings Mar 19 2015
Novo Nordisk On Diversity In Diabetes Trials: "We Could Do Better" Mar 19 2015
5 Breakout Stocks to Trade for Gains After the Fed's Bombshell Mar 19 2015
Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia® (lixisenatide) Mar 19 2015
Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia(r) (lixisenatide) Mar 19 2015
Investors Relieved? Akorn Stock Retakes 50-Day Line Mar 18 2015
SANOFI Financials Mar 18 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK